These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8973778)

  • 1. Ultrasound protocol and quality control procedures in the European Lacidipine Study on Atherosclerosis (ELSA).
    Mercuri M; Tang R; Phillips RM; Bond MG
    Blood Press Suppl; 1996; 4():20-3. PubMed ID: 8973778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline reproducibility of B-mode ultrasonic measurement of carotid artery intima-media thickness: the European Lacidipine Study on Atherosclerosis (ELSA).
    Tang R; Hennig M; Thomasson B; Scherz R; Ravinetto R; Catalini R; Rubba P; Zanchetti A; Bond MG
    J Hypertens; 2000 Feb; 18(2):197-201. PubMed ID: 10694188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis.
    Zanchetti A; Bond MG; Hennig M; Neiss A; Mancia G; Dal Palù C; Hansson L; Magnani B; Rahn KH; Reid J; Rodicio J; Safar M; Eckes L; Ravinetto R
    J Hypertens; 1998 Jul; 16(7):949-61. PubMed ID: 9794735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential modification of plaque behavior through the European lacidipine study on atherosclerosis.
    Bond MG; Mercuri M
    J Cardiovasc Pharmacol; 1995; 25 Suppl 3():S11-6. PubMed ID: 8852539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial.
    Zanchetti A; Bond MG; Hennig M; Neiss A; Mancia G; Dal Palù C; Hansson L; Magnani B; Rahn KH; Reid JL; Rodicio J; Safar M; Eckes L; Rizzini P;
    Circulation; 2002 Nov; 106(19):2422-7. PubMed ID: 12417537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness.
    Zanchetti A; Hennig M; Baurecht H; Tang R; Cuspidi C; Carugo S; Mancia G
    J Hypertens; 2007 Dec; 25(12):2463-70. PubMed ID: 17984668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the benefits of an antihypertensive agent using trials based on event and organ damage: the Systolic Hypertension in the Elderly Long-term Lacidipine (SHELL) trial and the European Lacidipine Study on Atherosclerosis (ELSA).
    Zanchetti A
    J Hypertens Suppl; 1995 Dec; 13(4):S35-9. PubMed ID: 8824685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The preliminary clinical evidence from the ELSA study. The European Lacidipine Study on Atherosclerosis].
    Leonetti G
    Ann Ital Med Int; 1995 Oct; 10 Suppl():74S-77S. PubMed ID: 8562272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality control of B-mode ultrasonic measurement of carotid artery intima-media thickness: the European Lacidipine Study on Atherosclerosis.
    Tang R; Hennig M; Bond MG; Hollweck R; Mancia G; Zanchetti A;
    J Hypertens; 2005 May; 23(5):1047-54. PubMed ID: 15834291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction, hypertension and atherosclerosis. A review of the effects of lacidipine.
    Haller H; Cosentino F; Lüscher TF
    Drugs R D; 2002; 3(5):311-23. PubMed ID: 12455152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac structural and functional changes during long-term antihypertensive treatment with lacidipine and atenolol in the European Lacidipine Study on Atherosclerosis (ELSA).
    Agabiti-Rosei E; Trimarco B; Muiesan ML; Reid J; Salvetti A; Tang R; Hennig M; Baurecht H; Parati G; Mancia G; Zanchetti A;
    J Hypertens; 2005 May; 23(5):1091-8. PubMed ID: 15834297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lacidipine: a review of its use in the management of hypertension.
    McCormack PL; Wagstaff AJ
    Drugs; 2003; 63(21):2327-56. PubMed ID: 14524737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of carotid atherosclerosis in hypertension: preliminary baseline data from the European Lacidipine Study on Atheroscelerosis (ELSA).
    Zanchetti A
    Blood Press Suppl; 1996; 4():30-5. PubMed ID: 8973780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Data collection and statistical analyses in ELSA. European Lacidipine Study on Atherosclerosis.
    Hennig M; Neiss A
    Blood Press Suppl; 1996; 4():24-9. PubMed ID: 8973779
    [No Abstract]   [Full Text] [Related]  

  • 15. Different relation between 24-h blood pressure and distensibility at different peripheral arteries. Data from the European Lacidipine Study on Atherosclerosis (ELSA).
    Giannattasio C; Failla M; Hennig M; Hollweck R; Laurent S; Mallion JM; Reid J; Safar M; Bond G; Zanchetti A; Mancia G
    J Hypertens; 2005 Mar; 23(3):557-62. PubMed ID: 15716697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absolute and relative changes in carotid intima-media thickness and atherosclerotic plaques during long-term antihypertensive treatment: further results of the European Lacidipine Study on Atherosclerosis (ELSA).
    Zanchetti A; Bond MG; Hennig M; Tang R; Hollweck R; Mancia G; Eckes L; Micheli D;
    J Hypertens; 2004 Jun; 22(6):1201-12. PubMed ID: 15167456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ELSA Studies studies progression of atherosclerosis. Calcium antagonist arrests the process more than a beta-blocker].
    Einecke D
    MMW Fortschr Med; 2001 Jul; 143(26-27):6. PubMed ID: 11481923
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of lacidipine on the carotid intimal hyperplasia induced by cuff injury.
    Soma MR; Donetti E; Parolini C; Barberi L; Paoletti R; Fumagalli R; Catapano AL
    J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S71-4. PubMed ID: 7609512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium, calcium antagonists and experimental atherosclerosis.
    Paoletti R; Corsini A; Soma MR; Bernini F
    Blood Press Suppl; 1996; 4():12-5. PubMed ID: 8973776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compliance studies in ELSA. European Lacidipine Study of Atherosclerosis.
    Giannattasio C; Boutouyrie P; Glen S; Mallion J; Reid J; Laurent S; Mancia G
    Blood Press Suppl; 1996; 4():39-43. PubMed ID: 8973782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.